Stijn Santen Triarii

MSc chemistry and chemical engineering

06 204 22 661
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stijn Santen works for Triarii as workgroup leader on dialogue and decision making in the Dutch energy transition with stakeholders in energy companies, governments and research institutes in the EU project R&Dialogue.

Stijn Santen holds an MSc in chemistry and chemical engineering at the University of Amsterdam and has worked for 18 years in Shell lately as global business manager CO2 before starting his company CO2-Net B.V. in 2005. He is the architect of the first commercially successful CO2 pipeline projects; Shell-Omya (1998) and Shell-OCAP (2005), where the latter is one the largest energy efficiency projects implemented in the Netherlands.

He acted as visiting professor at the Oil & Gas University of General Electric in Firenze, Italy in 2005 and 2006 teaching energy markets, energy policies and climate change and published his vision on innovation in “Managing technology and innovation” by Routledge Publishers. From 2006 till 2009 he developed and implemented the 50 % CO2 reduction strategy for Rotterdam leading to the development of the Rotterdam Climate Initiative. From 2009 till 2011 he was partner in the European program CO2Europipe on CO2 transport networks. In 2012 he led the EU CO2 transport working group in the European Zero Emission Platform ZEP together with National Grid.


Triarii news

March 2017: The article "Defence and Security stimulates innovative power of Dutch industry" builds its case on recent Triarii research of this industry.

Read more ...

 

November 2016: Triarii starts the initiative we save energy to help house buyers make their house more energy efficient, before they even move in.

Read more ...

 

October 2016: The "One Planet" exhibition in the Museon in The Hague (NL) was opened on 24 October 2016 by UN-chief Ban Ki Moon. Part of this is the biological toilet of PRISTO, a project of the Ghanean company Biofilcom and Triarii.

Read more ...